Lipid Nanoparticles for Short Interfering RNA Delivery

The discovery of RNA interference (RNAi) in mammalian cells has created a new class of therapeutics based on the reversible silencing of specific disease-causing genes. This therapeutic potential depends on the ability to deliver inducers of RNAi, such as short-interfering RNA (siRNA) and micro-RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Alex K.K., Tam, Yuen Yi C., Cullis, Pieter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149983/
https://www.ncbi.nlm.nih.gov/pubmed/25409604
http://dx.doi.org/10.1016/B978-0-12-800148-6.00004-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149983/
https://www.ncbi.nlm.nih.gov/pubmed/25409604
http://dx.doi.org/10.1016/B978-0-12-800148-6.00004-3

Ejemplares similares